Welcome Kelly Dooley, MD, PhD, MPH as the new Director of the Division of Infectious Diseases!
June 30, 2022
The Vanderbilt TB Center is excited to welcome Kelly Dooley to VUMC!
Kelly Dooley, MD, PhD, MPH, has been appointed Addison B. Scoville Jr. Professor of Medicine and director of the Division of Infectious Diseases in the Department of Medicine at Vanderbilt University Medical Center, effective Sept. 12.
Nancy Séraphin, MPH, PhD visits Vanderbilt TB Center
June 28, 2022
Nancy Séraphin, MPH, PhD, Research Assistant Professor in the Department of Medicine, Division of Infectious Diseases and Global Medicine (IDGM), and the Emerging Pathogens Institute (EPI) at the University of Florida visited VUMC between June 13th-15th. Her visit was highlighted by meetings with the TB Center team, collaborative discussions with researchers at VUMC, and the presentation of a guest lecture entitled: "The public health importance of Mycobacterium tuberculosis intra-host genetic variability”.
Vanderbilt TB Center wins Joe B. Ware Partner Service Award
June 20, 2022
During the 2022 Annual Conference of the National Tuberculosis Controllers Association, The Vanderbilt TB Center was awarded the Joe B. Ware Partner Service Award.
The award “recognizes an organization that has made a significant effort and/or contribution to the mission of TB control and prevention through partnership activities with public health TB programs.”
VTC hosts visitors from Brazil, South Africa, UW for grant project meeting
June 14, 2022
Vanderbilt Tuberculosis Center recently hosted a meeting of researchers involved in our LTBI R01 project “Immunogenetic predictors of active and incipient TB in HIV-negative and -positive close TB contacts” (NIH R01AI147765). The event, which took place between May 31st and June 2nd, included presentations about ongoing research and initial data, working group sessions, and breakout meetings.
WHO Global TB Report was released!
October 28, 2021
Each year, the WHO Global TB Report provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets.
New RePORT-Brazil publication: The Effect of Diabetes and Prediabetes on Anti-tuberculosis Treatment Outcomes: A Multi-center Prospective Cohort Study!
October 27, 2021
The Effect of Diabetes and Prediabetes on Anti-tuberculosis Treatment Outcomes: A Multi-center Prospective Cohort Study was generated from the RePORT-Brazil collaboration, led by Maria Arriaga, and published in The Journal of Infectious Diseases
Background: It is unclear whether diabetes or prediabetes affect unfavorable treatment outcomes and death in people with tuberculosis (PWTB).
Welcome Rebecca “Ribka” Berhanu, MD, as a new Assistant Professor in the Division of Infectious Disease!
September 30, 2021
Dr. Berhanu is an infectious diseases physician and clinical researcher. She is originally from Addis Ababa, Ethiopia. She completed her undergraduate degree at Stanford University and her medical degree at the Baylor College of Medicine. Ribka did her clinical training in internal medicine at the University of Chicago and her fellowship in infectious diseases at the University of North Carolina. She subsequently completed a post-doctoral fellowship at the Boston University School of Public Health.
New RePORT-Brazil publication: Determinants of losses in the latent tuberculosis infection cascade of care in Brazil
September 30, 2021
Determinants of losses in the latent tuberculosis infection cascade of care in Brazil publication was generated from the RePORT-Brazil collaboration, and published in BMJ Global Health
Introduction: Factors associated with losses in the latent tuberculosis infection (LTBI) cascade of care in contacts of patients with tuberculosis (TB) were investigated in a multicentre prospective cohort from highly endemic regions in Brazil.
New RePORT-Brazil publication: A clinical prediction model for unsuccessful pulmonary tuberculosis treatment outcomes
July 14, 2021
A clinical prediction model for unsuccessful pulmonary tuberculosis treatment outcomes scientific publication was generated from the RePORT-Brazil collaboration, led by Dr. Lauren Peetluk, and published in JID (Journal of Infectious Disease).
University of Washington's 4th Annual Advanced TB Research Training Course - Sept 13-17, 2021
July 14, 2021
The University of Washington's Department of Global Health and the Tuberculosis Research and Training Center (TRTC) are accepting applications for the 4th Annual Advanced TB Research Training Course. The course will be held as a Virtual Only course September 13 - 17, 2021.